4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-26-390506
Co-Chief Executive Officer sold 30,464 shares at an average $32.18 ($980,263)
From the SEC's structured data for this filing
Trades in this filing
Klee Justin B. · Co-Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-10 | Sale : show line 1 in the form | −29,025 | $32.13 | $932,553 | 3,614,495 | D |
| 2026-09-10 | Sale : show line 2 in the form | −1,439 | $33.16 | $47,710 | 3,613,056 | D |
| Open-market sales · 30,464 sh · avg $32.18 · $980,263 | ||||||
Loading xslF345X06/ownership.xml…